CiToxLAB Scantox Information

The CiToxLAB Group offers a comprehensive range of preclinical services and specialty safety evaluation services to meet the needs of pharmaceutical, biotechnology and chemical companies worldwide. Our four CiToxLAB international facilities in France, Canada, Denmark and Hungary carry out studies in general and reproductive toxicology, carcinogenicity, bioanalysis, DMPK, Pharmacokinetics, Toxicokinetics, ADME, immunology and safety pharmacology. The group has special expertise in areas such as inhalation or intra-nasal toxicology, radiation safety (ARS), NHPs and minipigs. Environmental studies are a further specialty including ecotoxicology and those related to REACH regulations. Together with partners such as Atlanbio (St Nazaire, France) Stemina (Madison, USA), CiToxLAB also provides services such as clinical bioanalysis and embryonic stem cell biomarker discovery. CiToxLAB now offers flexibility, direct contact to scientists, easy access to management and local, smart-sized facilities. Aggressive scheduling, increased size and capacity, turnkey solutions of global packages supported by project managers and broader geographic proximity are core values of CITOXLAB. Contact our team of experts: www.citoxlab.com CiToxLAB Scantox is the Danish laboratory in the CiToxLAB Group and is the largest non-clinical Contract Research Organization in Scandinavia. Our studies form the basis of regulatory authorization of pharmaceutical, bio-pharmaceutical as well as other chemical products. The main purpose of these studies is to ensure public health and safety. Our clients are both Danish and international pharmaceutical and biotechnology companies. Our specialities in Denmark include minipigs in safety testing, GMP testing of finished pharmaceutical products for safety and potenct and biocompatibility of medical devices. In Denmark, we employ over 120 staff with high technical expertise, of which a large number are academics.